BioPharmSignal logoBioPharmSignal

Biotech News

Harrow Launches HarrowRx Platform

Harrow, Inc. (HROW)Harrow, Inc.Company update

HarrowRx to Simplify Access to Harrow Products and Integrate Into the Eyecare Practice Workflow, Providing a Single Prescribing Destination Within Existing Electronic Medical Record (EMR) Systems HarrowRx to Simplify Access to Harrow Products and Integrate Into the Eyecare Practice Workflow, Providing a Single Prescribing Destination Within Existing Electronic Medical Record (EMR) Systems

Related news

HROWHarrow, Inc.2026-08-06 11:00 EST

Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease

HROWHarrow, Inc.2026-10-05 11:00 EST

Harrow Closes Acquisition of TYRVAYA®

View all latest news

Harrow, Inc.

Ophthalmic Pharmaceutical Portfolio Harrow is a U.S. ophthalmic pharmaceutical company commercializing branded and compounded medicines for eye-care professionals. Its portfolio addresses conditions managed in optometry, ophthalmology and surgical settings. Dry-Eye Franchise VEVYE is a cyclosporine ophthalmic solution for the signs and...

Recent company news

HROWHarrow, Inc.2026-11-02 12:00 EST

Harrow Launches HarrowRx Platform

HROWHarrow, Inc.2026-10-05 11:00 EST

Harrow Closes Acquisition of TYRVAYA®

HROWHarrow, Inc.2026-09-30 11:00 EST

Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO

HROWHarrow, Inc.2026-09-01 11:00 EST

Harrow to Participate in Three Investor Conferences in September

HROWHarrow, Inc.2026-08-20 11:00 EST

Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections

Stock data

Close
26.04 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States